Combination Products Office Urges Companies To Call With Their Questions
This article was originally published in The Gray Sheet
Executive Summary
FDA's Office of Combination Products recommends that companies struggling with areas for which there is no clear FDA regulation or guidance consult directly with the office's staff
You may also be interested in...
Concept Papers Seek Industry Input On Combo Product Issues
FDA seeks feedback on two concept papers offering preliminary thoughts on adverse event reporting and on the number of applications needed for a combination product
Cross-Labeling Challenges Lack Easy Fix; Data Exclusivity Incentive Floated
Data exclusivity extensions have been proposed as an incentive to encourage drug firms to amend product labeling in deference to related devices, but FDA and industry reps warn of complications inherent in this strategy
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.